chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12-30-21 starting experiencing itching on stomach. Over night hives formed and spread to neck. Over the course of the next two days hives became widespread and extremely itchy, could not function normally, could not sleep.  Took antihistamines which provided no relief and colloidal oatmeal baths. used steriod cream on the flare ups. On Monday 1-3-22,  PCP telehealthed in prescription for prednisone. On prednisone and daily antihistimine hives are 50% controlled, however flare ups still occuring.  I cannot hold a phone to my ear or a pen in my hand without breaking out.  Taking an extreme toll on my physical and mental health.
03-29-2021 at 8:30am awoke with severe headache, left jaw pain and vision problem. Made appointment with eye doctor (April 1) . 03-30-2021, while shopping had a major stroke at 1:00pm. EMS took me to the Hospital. Admitted to ER, acute ischemic stroke, basilar artery thrombosis, atrial fibrillation. Blood clot removal by Neurological Radiologist. Discharged from Hospital April 2,2021. Still am being treated for atrial fibrillation and vision problems.
MIGRAINE REACTIONS TO SOUNDS; REGURGITATION; LAZY EYE ON THE LEFT SIDE; LEFT SIDE FACE MUSCLE LOOSE; NUMBNESS IN HANDS AND LEGS ARE PREDOMINATELY ON THE RIGHT SIDE; CHILLS; FEVER; This spontaneous report received from a consumer concerned a 79 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: high blood pressure, and patient had no lifestyle changes prior to high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: UNKNOWN) dose was not reported,1 total, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient visited the hospital for high blood pressure and while there, he was offered the Covid-19 vaccine, a few days later started to experience the symptoms, the patient experienced vertigo, nausea, chills, fever, regurgitates, spells of dizziness, blurred vision, migraine reactions to sounds. Patient experienced numbness in hands and legs are predominately on the right side, left side face muscle loose. Neurologist stated patient had severe headaches. Cardiologist stated that his heart was okay. Patient visited eye and ear infirmary specialist, doctor administered Botox injections into his ear. After a week of symptoms began seeking medical advice and had three exams KKG and two others. Neurologist stated points to a rare form of migraine. Treatment medications (dates unspecified) included: botulinum toxin type a. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from regurgitation, migraine reactions to sounds, lazy eye on the left side, numbness in hands and legs are predominately on the right side, left side face muscle loose, fever, and chills. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210817357- Covid-19 vaccine ad26.cov2.s- Migraine reactions to sounds. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY
Became very tired & drowsy in one hr; p/3 hrs extremely drowsy & slept x 14 hrs awakened x 3 during time but cont to feel drowsy; face flushed no temp; felt worn out following day;
Pt vax hepta B; 5 days after vax devel herpes zoster.
Fever, chills, body aches, swollen face & lips, headache, fast heartbeat, dizziness, mild difficulty breathing
pt recv vax 11SEP98 & broke out in rash all over "measles like";it broke out on Wednesday & faded by next day;fever 101 which responded to APAP;no other tx necessary;child did not act sick;
Patient received first booster shot on 6/14/22.  Woke up the next morning 6/15/22 with a swollen lymph node in the arm that she received the shot in.  She called her doctor who said it was relatively normal after a vaccine.  They gave her prednisone and advised her to take benadryl.  She felt better.  Then Thursday morning 6/16/22 she woke up and her armpit was significantly bigger and the breast on that side was swollen.  She continued benadryl and prednisone.  But by the afternoon it progressed to the middle of her chest.  She went to urgent care and by the time she got there the lymph nodes in her neck were swelling and her throat started closing.  They immediately gave her an epipen and IV steroids and she was fine.
First case of shingles after ZOSTAVAX; reporter had cases of shingles twice / she had a mild case of shingles; This spontaneous report was received from a consumer referring on herself a female patient of unknown age. The patient's medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.   On an unspecified date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) injection, as prophylaxis (dose, route of administration, anatomical site of injection, lot number, and expiration date were not reported).  On an unspecified date (also reported as after zoster vaccine live (ZOSTAVAX)), the patient experienced her first case of shingles (herpes zoster).   In approximately 2017, the patient was vaccinated with varicella zoster vaccine RGE (CHO) (SHINGRIX) solution for injection (dose, route of administration, anatomical site of injection, indication, lot number, and expiration date were not reported). The patient completed the series. Then, she had a mild second case of shingles (herpes zoster reactivation).   At the time of reporting, the patient recovered from herpes zoster. The outcome of herpes zoster reactivation was not reported. The causal relationship between the aforementioned events, zoster vaccine live (ZOSTAVAX) and varicella zoster vaccine RGE (CHO) (SHINGRIX), was not provided.
tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced COVID-19 (tested positive for COVID-19). At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-May-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  Patient was tested positive on the day he was scheduled to get his second dose.  No treatment information was provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
extreme congestion; Loss of appetite; nausea; fever; chills; headache; fatigue; dry cough; injection site pain; pain; This is a spontaneous report from a contactable consumer (patient). A 64-year-old non-pregnant female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6201, Expiry date: unknown), via an unspecified route of administration on 09Feb2021 at 03:00 PM (at the age of 64-year-old) on Left arm at single dose for covid-19 immunisation. The patient's medical history was not reported. Patient had unspecified other medications in two weeks. The patient previously took first dose of BNT162B2 (Lot number: EL9262) on 22Jan2021 at 02:30 PM on Left arm at single dose for covid-19 immunisation and had vancomycin and experienced drug allergy. The patient experienced Loss of appetite, nausea, fever, chills, headache, fatigue, dry cough, extreme congestion, pain at injection site and aches on 10Feb2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The patient was recovering from the events.  No follow-up attempts are possible. No further information is expected.
Narrative: Patient with bulbar ALS, admitted to hospice, however, expired within 42 days of receiving covid vaccine
Loss of hair on left side nape of neck. No treatments given, hair seems to be growing back now. No itching, redness, irritation, bumps, etc.
Information has been received from an office manager in a physicians office concerning a patient who was vaccinated with the first dose of ROTATEQ vaccine at 6 months of age. It was unknown if medical attention was sought. No further information is available.
Patient self-scheduled for the Janssen COVID-19 Vaccine. She had the 1st dose Moderna COVID-19 Vaccine on 01/18/2021. She stated she did not "know where to get the 2ns dose of Moderna" . She just wanted a second dose and choose to get the Janssen d/t availability at the time. No adverse reactions noted after 15 minutes of monitoring post vaccination.
Pt had resp infect @ time vax 03/15/96. Dec/30/97 dx w/shingles.Lesions "bead-like,papular,vesicular, anterior chest /axilla & back,spreading 2 days. 2/98  pt "max t100.6. No hx/exp chickenpox;
Patient experienced redness and a lot of swelling at the injection site. Area was also hot to the touch. Patient went to urgent care where they diagnosed him with and infection and prescribed him a steroid and antibiotic.
Delayed onset crushing headache; Tylenol and rest; 2 hours and counting.
Pt recv vax on 9/11/98; 0n 9/12/98 pt exp edema, erythema &tenderness at injection site (10cm x 9cm)
Pt returned due 3 dose of RABAVERT at HD at 3pm on 9/26/11. Father reports at 8pm 9/26 child experienced nausea, headache, stomach ache & 104 temps. At 130am 9/27/11 she experienced flu like symptoms. Weakness & soreness. 9/28/11 child improved & went to school.
Information was received on 13-JUL-2017 from a registered nurse regarding a 13 year old male patient. Medical history, concurrent conditions and concomitant medications were reported as none. On 12-JUL-2017, the patient was vaccinated with GARDASIL 9 (lot # N007931, exp 17-NOV-2019) intramuscularly (dose and site of administration not reported). On 13-JUL-2017, the patient experienced two nosebleeds. The patient did not experience any trauma to his nose. He did not seek medical attention as he was able to stop the nosebleeds on his own with pressure. The relationship between the nosebleeds and GARDASIL 9 was not provided. No further information was provided. Additional information has been requested.
37-year-old male comes in states he is having gross hematuria 2/18. Pt has been on Bactrim for the last 2 weeks, denies any fever or chills.  Pt having suprapubic pain but no scrotal pain.  Pt has generalized fatigue and weakness. COVID positive 2/19. Patient is A&O x 4. On room air. On bedrest. Continuous bladder irrigation is infusing 2/21. Pt had 1.9 L of fluid removed. Pt tolerated the tx well. One unit of PRBC given and tolerated process well no s/s of any distress noted 2/22. He is on room air, heart monitor is on, IV saline locked, foley in place 2/27. Writer removed 2.3 liters of fluid during treatment, vss, tolerated well, left upper arm fistula working well 3/1. Discharged 3/3.
Almost whole leg swollen/red given q-dryl 12.5 mg/5 ml 1 tsp four times a day as needed for 2 days.
This is what I?m experiencing. Described perfectly in article below. Basically a big hive on day 7/8 at site of injection.
This case was reported by a medical assistant and described the occurrence of injection site cellulitis in a 5 year old male pt who received Infanrix. On 10/6/04, the pt received the 5th dose of Infanrix in the right arm. Within 1 week of the 5th administration of Infanrix, on an unspecified date in 10/04, the pt experienced an unspecified injection site reaction; a dx of injection site cellulitis was made. The event had improved as of the time of initial reporting.
This spontaneous report was received from a medical assistant from a medical assistant and refers to a 9 month old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 18-OCT-2016, the patient was inadvertently administered a dose of VAQTA intramuscularly, lot # M015290 with expiration date 20-SEP-2017 (dose not reported). No adverse effects were reported. Additional information has been requested.
Spiking fever of 101.9; Headaches; Product administration interrupted; Product unavailable due to pandemic; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Spiking fever of 101.9), HEADACHE (Headaches), PRODUCT ADMINISTRATION INTERRUPTED (Product administration interrupted) and PRODUCT AVAILABILITY ISSUE (Product unavailable due to pandemic) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Product administration interrupted) and PRODUCT AVAILABILITY ISSUE (Product unavailable due to pandemic). On an unknown date, the patient experienced PYREXIA (Spiking fever of 101.9) and HEADACHE (Headaches). On 23-Jan-2021, PRODUCT ADMINISTRATION INTERRUPTED (Product administration interrupted) and PRODUCT AVAILABILITY ISSUE (Product unavailable due to pandemic) had resolved. At the time of the report, PYREXIA (Spiking fever of 101.9) and HEADACHE (Headaches) outcome was unknown. Not Provided          Patient was treated with antibiotics, steroids and had extensive bloodwork done.
The morning after the shot, I woke up with a sore arm, temperature kept going up/rising during the day, felt nauseous, dizzy, tired, warm stomach.
No additional AE details.; Nurse calling for TE evaluation of refrigerated products mentions vaccines were administered to 4 patients.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 19-APR-2022, the patient was vaccinated with HPV rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (valid lot #U032681, expiration date: 26-OCT-2023) (strength, dose and route of administration were not provided) as prophylaxis. A temperature evaluation of refrigerated products was made and it was reported that for 4 hours 2 minutes 0 seconds, the temperature vaccine was 58.7 Fahrenheit (F) (Product storage error). No previous temperature excursion occurred. There was no adverse event reported.  This is one of several reports received from the same reporter (captured on #2205USA000274, #2205USA000427 and #2205USA000252). ; Sender's Comments:  US-009507513-2205USA000274: US-009507513-2205USA000427: US-009507513-2205USA000252:
First dose of Moderna vaccine in March2021 and had a reaction to it; Localized reaction; Not going to get the second dose but recently decided they may want to, receive her second dose; rash; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (First dose of Moderna vaccine in March2021 and had a reaction to it), HYPERSENSITIVITY (Localized reaction), INTENTIONAL PRODUCT USE ISSUE (Not going to get the second dose but recently decided they may want to, receive her second dose) and RASH (rash) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039C21A) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (First dose of Moderna vaccine in March2021 and had a reaction to it), HYPERSENSITIVITY (Localized reaction), INTENTIONAL PRODUCT USE ISSUE (Not going to get the second dose but recently decided they may want to, receive her second dose) and RASH (rash). At the time of the report, VACCINATION COMPLICATION (First dose of Moderna vaccine in March2021 and had a reaction to it) and INTENTIONAL PRODUCT USE ISSUE (Not going to get the second dose but recently decided they may want to, receive her second dose) outcome was unknown and HYPERSENSITIVITY (Localized reaction) and RASH (rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided. Patient went to her physician and was cleared to receive the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow up received and contains no new information. On 27-Jul-2021: Follow up received- Dose-2 information start date batch number/pt demographics update
Approximately 3 days after my 2nd dose I experienced the following symptoms: Extreme raising heart rate, Cold Blisters all over my mouth and nose, Muscle soreness, Fever, Chills, Fatigue, Hives (Rash reaction). I took Tylenol and Benadryl to help ease the symptoms. By Friday the 14th my cold blisters got worse and had a televisit the next day (Saturday) and the doctor said it might've been from a stress factor from the vaccine. She thought it was strange because she has never heard anything like it. It took about 3 weeks for me to recover from the overall side effects.
expired vaccine used/ Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022.; no adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used/ Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022.) and NO ADVERSE EVENT (no adverse event) in a 73-year-old male patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used/ Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022.) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used/ Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired vaccine used/ Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022.).    Patient age was reported as 73 Year 1 Month. It was reported that lot 070H21A, that has an expiration date of 7-Apr-2022. Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022. No concomitant medication were reported. No treatment medication were reported.
Chills 2/16/22 10 pm to 3 am, fever 2/17/21 8:30 am, fever gone 9:15 am, fever 11 am, fever gone 11:30 am.  Better after that.
Information has been received from a physician concerning an approximately 4 month old patient who on unspecified dates was vaccinated with two 0.5 ml doses of Proquad. Subsequently, the patient experienced swelling at injection site after the second dose of Proquad. Unspecified medical attention was sought. The patient recovered on an unspecified date. No product quality complaint was involved. Additional information has been requested.
for first 24 hours seemed okay, but starting about 7pm about 24.5 hrs later, started to feel "peaked", tired and by about 8:30pm had a low grade fever of 100.4 degrees F - took 2 aspirin and went to bed. Okay by morning. No other adverse events.
recent COVID + diagnosis/Covid exposure; recent COVID + diagnosis/Covid exposure; This is a spontaneous report from contactable nurses. This nurse reported similar events for 4 patients. This is the third of four reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 22Dec2020 for COVID-19 immunisation. Medical history and concomitant medication were not reported. Reporter stated 4 employees that had been vaccinated with a 1st dose had to defer to 02Feb2021 due to recent COVID + diagnosis/COVID exposure. Event took place after use of product. Covid test was positive. The outcome of events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, it is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021035084 the same reporter, product and adverse events in different patients
Stroke; This is a spontaneous report from a non-contactable consumer.  A consumer reported that a female patient (niece) of an unknown age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), via an unspecified route of administration in May2021 as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient had her Pfizer vaccine in the month of May and had a stroke on an unknown date. Her neurologist said it's most probably because of the vaccine. The outcome of the event was unknown.    No follow-up attempts are possible. No further information is expected.